<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Holmes | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/heightyew9/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/heightyew9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Holmes.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">59da085b39e4e736b21a62802b9b1af1</guid>
				<title>Holmes posted an update: We found that polygenic scores were associated beyond APOE [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41849/</link>
				<pubDate>Sat, 08 Feb 2025 11:16:03 -0800</pubDate>

									<content:encoded><![CDATA[<p>We found that polygenic scores were associated beyond APOE with clinical diagnosis, CSF-tau levels and, to a minor degree, with progressive atrophy. However, for many other tested traits such as clinical disease progression, CSF amyloid, cognitive decline and cortical amyloid load, the additional effects of polygenic burden beyond APOE were of&hellip;<span class="activity-read-more" id="activity-read-more-41849"><a href="http://www.nationalboardinstitute.com/activity/p/41849/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f5bce6927b533a1cb397595bdff45eb4</guid>
				<title>Holmes posted an update: Concisely, the GSLM with coefficients of determination (R2) [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36568/</link>
				<pubDate>Sun, 02 Feb 2025 11:18:03 -0800</pubDate>

									<content:encoded><![CDATA[<p>Concisely, the GSLM with coefficients of determination (R2) 99.957% and root mean squared error (RMSE) of 2.121% outperformed the SVM-FFA with R2 99.59%, RMSE 3.27%, ANN with R2 99.56%, RMSE 3.3%, ANFIS with R2 98.9%, RMSE 4.3%, GP with R2 99.89%, RMSE 3.47%, GEP with R2 94.75%, RMSE 4.15% for forecasting weekly time series. In forecasting monthly&hellip;<span class="activity-read-more" id="activity-read-more-36568"><a href="http://www.nationalboardinstitute.com/activity/p/36568/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9d02fc28bba2e1d534637194c3375019</guid>
				<title>Holmes posted an update: injury burden. LEVEL OF EVIDENCE Prognostic, level [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32587/</link>
				<pubDate>Tue, 28 Jan 2025 19:03:56 -0800</pubDate>

									<content:encoded><![CDATA[<p>injury burden. LEVEL OF EVIDENCE Prognostic, level III.BACKGROUND Patients with blunt cerebrovascular injuries (BCVI) are at risk of thromboembolic stroke. Although primary prevention with antithrombotic therapy is widely used in this setting, its effectiveness is not well defined, and requires further investigation. The aim of this study was to&hellip;<span class="activity-read-more" id="activity-read-more-32587"><a href="http://www.nationalboardinstitute.com/activity/p/32587/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">22be55a705031d5c3dec290c979995a9</guid>
				<title>Holmes became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32546/</link>
				<pubDate>Tue, 28 Jan 2025 18:58:13 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>